Merck snags Chinese cancer drug for up to US$3.3 billion
MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million ...
MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million ...
The price is at the top of the 1,865 rupees to 1,960 rupees range flagged to investors when the deal ...
CROP trader Olam Group will pay a US$3.3 million fine for delayed reporting of cotton sales to the US Department ...
SAUDI Arabia posted a budget deficit of 12.387 billion riyals (S$4.4 billion) in the first quarter of 2024, the finance ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
© 2024 The New York Journals. All Rights Reserved.